Tuesday, 8 December 2015
Global Alzheimer Market Report 2015 Edition
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as depression, anxiety, delusion, hallucination and agitation. Alzheimer's disease is the main source of dementia all over the world and can be either a major or a mild neurocognitive disorder. Alzheimer’s is likely to grow exponentially with increase in ageing population thus, providing a significant market opportunity in the coming years.
Complete Report Available at http://www.marketreportsonline.com/429709.html.
The current market for Alzheimer’s disease drugs is limited as only few drugs have been approved thus, defining a healthy scope of introduction of new drugs in the market in the coming years. The healthcare costs associated with Alzheimer’s are also anticipated to rise considerably since only limited treatment options are available in the market. The Alzheimer market expects introduction of innovative small molecules, biopharmaceuticals and disease modifying agents that would help transform the pattern of Alzheimer’s disease.
Increasing ageing population, growing population of women, rising life expectancy, increasing healthcare expenditure, improving economic conditions, and increasing global spending on medicines are some of the major factors contributing to the growth of Alzheimer’s disease market. However, the growth of the market is hindered by certain challenges including lack of availability of effective treatment options, problems in detection and diagnosis, and insufficient research funding.
Purchase a copy of alzheimer market research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=429709.
The report, “Global Alzheimer Market” analyzes the currently prevailing condition of the market along with its future scope of development. The global alzheimer market along with specific markets of the U.S., Europe (including the UK) and Asia-Pacific are being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the alzheimer market are being profiled, along with their key financials and strategies for growth.
Browse All Pharmaceuticals, Market Research Reports at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.
Other Related Reports on Pharmaceuticals Market:
Global Diabetes Market Report: 2015 Edition: Diabetes mellitus, or simply diabetes, is a chronic disease that occurs when the pancreas is no longer able to make insulin, or when the body cannot make good use of the insulin it produces. Insulin is a hormone made by the pancreas that acts like a key to let glucose from the food we eat pass from the blood stream into the cells in the body to produce energy. All carbohydrate foods are broken down into glucose in the blood. Insulin helps glucose get into the cells. Type 1 diabetes, Type 2 diabetes and Gestational diabetes are the three types of diabetes.
Global Osteoporosis Market, Patients, Companies & Forecast: Osteoporosis is a silent disease until it is complicated by fractures that occur following minimal trauma or, in some cases, with no trauma. Globally Osteoporosis is expected to be more than US$ 40 Billion market by 2019. China and India together have close to 80% of osteoporosis patients worldwide. Whereas this in case of hip fracture cases both the countries China and India have more than 60% patients. But when we study Osteoporosis in market terms then United States controls the highest market share followed by China and Japan. Amgen and Eli Lilly are two dominant players in Osteoporosis drugs market.